{"transactions":[{"id":4626579,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2026-09-25T00:36:06.000Z","date":"2026-09-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":13398,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the Effective Time, each option to purchase Ordinary Shares outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested (a \"Company Option\"), was cancelled and converted into the right to receive an amount in cash, without interest, equal to (i) the excess, if any, of the Per Share Cash Consideration over the exercise price of such Company Option, multiplied by (ii) the number of Ordinary Shares underlying such Company Option plus (iii) one CVR for each Ordinary Share underlying such Company Option. However, any Company Option that has an exercise price per Ordinary Share that is greater than or equal to the Per Share Cash Consideration was cancelled and ceased to exist and the holder of any such Company Option was not entitled to payment of any consideration therefor."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the Effective Time, each option to purchase Ordinary Shares outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested (a \"Company Option\"), was cancelled and converted into the right to receive an amount in cash, without interest, equal to (i) the excess, if any, of the Per Share Cash Consideration over the exercise price of such Company Option, multiplied by (ii) the number of Ordinary Shares underlying such Company Option plus (iii) one CVR for each Ordinary Share underlying such Company Option. However, any Company Option that has an exercise price per Ordinary Share that is greater than or equal to the Per Share Cash Consideration was cancelled and ceased to exist and the holder of any such Company Option was not entitled to payment of any consideration therefor."}],"balance_after":0,"derivative":{"exercise_price":16.64,"expiration_date":"2036-06-11","underlying":"Ordinary Shares","underlying_shares":13398},"source":{"system":"sec-edgar","filing":"0001625377-26-000007","document":"form4-09252026_120902.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1625377/000162537726000007/form4-09252026_120902.xml","form_type":"4"}},{"id":4626578,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2026-09-25T00:36:06.000Z","date":"2026-09-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":24258,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the Effective Time, each option to purchase Ordinary Shares outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested (a \"Company Option\"), was cancelled and converted into the right to receive an amount in cash, without interest, equal to (i) the excess, if any, of the Per Share Cash Consideration over the exercise price of such Company Option, multiplied by (ii) the number of Ordinary Shares underlying such Company Option plus (iii) one CVR for each Ordinary Share underlying such Company Option. However, any Company Option that has an exercise price per Ordinary Share that is greater than or equal to the Per Share Cash Consideration was cancelled and ceased to exist and the holder of any such Company Option was not entitled to payment of any consideration therefor."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the Effective Time, each option to purchase Ordinary Shares outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested (a \"Company Option\"), was cancelled and converted into the right to receive an amount in cash, without interest, equal to (i) the excess, if any, of the Per Share Cash Consideration over the exercise price of such Company Option, multiplied by (ii) the number of Ordinary Shares underlying such Company Option plus (iii) one CVR for each Ordinary Share underlying such Company Option. However, any Company Option that has an exercise price per Ordinary Share that is greater than or equal to the Per Share Cash Consideration was cancelled and ceased to exist and the holder of any such Company Option was not entitled to payment of any consideration therefor."}],"balance_after":0,"derivative":{"exercise_price":9.39,"expiration_date":"2035-05-18","underlying":"Ordinary Shares","underlying_shares":24258},"source":{"system":"sec-edgar","filing":"0001625377-26-000007","document":"form4-09252026_120902.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1625377/000162537726000007/form4-09252026_120902.xml","form_type":"4"}},{"id":4626577,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2026-09-25T00:36:06.000Z","date":"2026-09-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":23576,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the Effective Time, each option to purchase Ordinary Shares outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested (a \"Company Option\"), was cancelled and converted into the right to receive an amount in cash, without interest, equal to (i) the excess, if any, of the Per Share Cash Consideration over the exercise price of such Company Option, multiplied by (ii) the number of Ordinary Shares underlying such Company Option plus (iii) one CVR for each Ordinary Share underlying such Company Option. However, any Company Option that has an exercise price per Ordinary Share that is greater than or equal to the Per Share Cash Consideration was cancelled and ceased to exist and the holder of any such Company Option was not entitled to payment of any consideration therefor."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the Effective Time, each option to purchase Ordinary Shares outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested (a \"Company Option\"), was cancelled and converted into the right to receive an amount in cash, without interest, equal to (i) the excess, if any, of the Per Share Cash Consideration over the exercise price of such Company Option, multiplied by (ii) the number of Ordinary Shares underlying such Company Option plus (iii) one CVR for each Ordinary Share underlying such Company Option. However, any Company Option that has an exercise price per Ordinary Share that is greater than or equal to the Per Share Cash Consideration was cancelled and ceased to exist and the holder of any such Company Option was not entitled to payment of any consideration therefor."}],"balance_after":0,"derivative":{"exercise_price":9.49,"expiration_date":"2034-05-07","underlying":"Ordinary Shares","underlying_shares":23576},"source":{"system":"sec-edgar","filing":"0001625377-26-000007","document":"form4-09252026_120902.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1625377/000162537726000007/form4-09252026_120902.xml","form_type":"4"}},{"id":4626576,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2026-09-25T00:36:06.000Z","date":"2026-09-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":22044,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the Effective Time, each option to purchase Ordinary Shares outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested (a \"Company Option\"), was cancelled and converted into the right to receive an amount in cash, without interest, equal to (i) the excess, if any, of the Per Share Cash Consideration over the exercise price of such Company Option, multiplied by (ii) the number of Ordinary Shares underlying such Company Option plus (iii) one CVR for each Ordinary Share underlying such Company Option. However, any Company Option that has an exercise price per Ordinary Share that is greater than or equal to the Per Share Cash Consideration was cancelled and ceased to exist and the holder of any such Company Option was not entitled to payment of any consideration therefor."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the Effective Time, each option to purchase Ordinary Shares outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested (a \"Company Option\"), was cancelled and converted into the right to receive an amount in cash, without interest, equal to (i) the excess, if any, of the Per Share Cash Consideration over the exercise price of such Company Option, multiplied by (ii) the number of Ordinary Shares underlying such Company Option plus (iii) one CVR for each Ordinary Share underlying such Company Option. However, any Company Option that has an exercise price per Ordinary Share that is greater than or equal to the Per Share Cash Consideration was cancelled and ceased to exist and the holder of any such Company Option was not entitled to payment of any consideration therefor."}],"balance_after":0,"derivative":{"exercise_price":10.95,"expiration_date":"2033-05-01","underlying":"Ordinary Shares","underlying_shares":22044},"source":{"system":"sec-edgar","filing":"0001625377-26-000007","document":"form4-09252026_120902.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1625377/000162537726000007/form4-09252026_120902.xml","form_type":"4"}},{"id":4626575,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2026-09-25T00:36:06.000Z","date":"2026-09-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":28000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the Effective Time, each option to purchase Ordinary Shares outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested (a \"Company Option\"), was cancelled and converted into the right to receive an amount in cash, without interest, equal to (i) the excess, if any, of the Per Share Cash Consideration over the exercise price of such Company Option, multiplied by (ii) the number of Ordinary Shares underlying such Company Option plus (iii) one CVR for each Ordinary Share underlying such Company Option. However, any Company Option that has an exercise price per Ordinary Share that is greater than or equal to the Per Share Cash Consideration was cancelled and ceased to exist and the holder of any such Company Option was not entitled to payment of any consideration therefor."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the Effective Time, each option to purchase Ordinary Shares outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested (a \"Company Option\"), was cancelled and converted into the right to receive an amount in cash, without interest, equal to (i) the excess, if any, of the Per Share Cash Consideration over the exercise price of such Company Option, multiplied by (ii) the number of Ordinary Shares underlying such Company Option plus (iii) one CVR for each Ordinary Share underlying such Company Option. However, any Company Option that has an exercise price per Ordinary Share that is greater than or equal to the Per Share Cash Consideration was cancelled and ceased to exist and the holder of any such Company Option was not entitled to payment of any consideration therefor."}],"balance_after":0,"derivative":{"exercise_price":10.15,"expiration_date":"2032-04-25","underlying":"Ordinary Shares","underlying_shares":28000},"source":{"system":"sec-edgar","filing":"0001625377-26-000007","document":"form4-09252026_120902.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1625377/000162537726000007/form4-09252026_120902.xml","form_type":"4"}},{"id":4626574,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2026-09-25T00:36:06.000Z","date":"2026-09-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":6000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the Effective Time, each option to purchase Ordinary Shares outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested (a \"Company Option\"), was cancelled and converted into the right to receive an amount in cash, without interest, equal to (i) the excess, if any, of the Per Share Cash Consideration over the exercise price of such Company Option, multiplied by (ii) the number of Ordinary Shares underlying such Company Option plus (iii) one CVR for each Ordinary Share underlying such Company Option. However, any Company Option that has an exercise price per Ordinary Share that is greater than or equal to the Per Share Cash Consideration was cancelled and ceased to exist and the holder of any such Company Option was not entitled to payment of any consideration therefor."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the Effective Time, each option to purchase Ordinary Shares outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested (a \"Company Option\"), was cancelled and converted into the right to receive an amount in cash, without interest, equal to (i) the excess, if any, of the Per Share Cash Consideration over the exercise price of such Company Option, multiplied by (ii) the number of Ordinary Shares underlying such Company Option plus (iii) one CVR for each Ordinary Share underlying such Company Option. However, any Company Option that has an exercise price per Ordinary Share that is greater than or equal to the Per Share Cash Consideration was cancelled and ceased to exist and the holder of any such Company Option was not entitled to payment of any consideration therefor."}],"balance_after":0,"derivative":{"exercise_price":20.35,"expiration_date":"2031-04-26","underlying":"Ordinary Shares","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001625377-26-000007","document":"form4-09252026_120902.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1625377/000162537726000007/form4-09252026_120902.xml","form_type":"4"}},{"id":4626573,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2026-09-25T00:36:06.000Z","date":"2026-09-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":6000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the Effective Time, each option to purchase Ordinary Shares outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested (a \"Company Option\"), was cancelled and converted into the right to receive an amount in cash, without interest, equal to (i) the excess, if any, of the Per Share Cash Consideration over the exercise price of such Company Option, multiplied by (ii) the number of Ordinary Shares underlying such Company Option plus (iii) one CVR for each Ordinary Share underlying such Company Option. However, any Company Option that has an exercise price per Ordinary Share that is greater than or equal to the Per Share Cash Consideration was cancelled and ceased to exist and the holder of any such Company Option was not entitled to payment of any consideration therefor."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the Effective Time, each option to purchase Ordinary Shares outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested (a \"Company Option\"), was cancelled and converted into the right to receive an amount in cash, without interest, equal to (i) the excess, if any, of the Per Share Cash Consideration over the exercise price of such Company Option, multiplied by (ii) the number of Ordinary Shares underlying such Company Option plus (iii) one CVR for each Ordinary Share underlying such Company Option. However, any Company Option that has an exercise price per Ordinary Share that is greater than or equal to the Per Share Cash Consideration was cancelled and ceased to exist and the holder of any such Company Option was not entitled to payment of any consideration therefor."}],"balance_after":0,"derivative":{"exercise_price":30.14,"expiration_date":"2030-04-27","underlying":"Ordinary Shares","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001625377-26-000007","document":"form4-09252026_120902.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1625377/000162537726000007/form4-09252026_120902.xml","form_type":"4"}},{"id":4626572,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2026-09-25T00:36:06.000Z","date":"2026-09-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":6000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the Effective Time, each option to purchase Ordinary Shares outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested (a \"Company Option\"), was cancelled and converted into the right to receive an amount in cash, without interest, equal to (i) the excess, if any, of the Per Share Cash Consideration over the exercise price of such Company Option, multiplied by (ii) the number of Ordinary Shares underlying such Company Option plus (iii) one CVR for each Ordinary Share underlying such Company Option. However, any Company Option that has an exercise price per Ordinary Share that is greater than or equal to the Per Share Cash Consideration was cancelled and ceased to exist and the holder of any such Company Option was not entitled to payment of any consideration therefor."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the Effective Time, each option to purchase Ordinary Shares outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested (a \"Company Option\"), was cancelled and converted into the right to receive an amount in cash, without interest, equal to (i) the excess, if any, of the Per Share Cash Consideration over the exercise price of such Company Option, multiplied by (ii) the number of Ordinary Shares underlying such Company Option plus (iii) one CVR for each Ordinary Share underlying such Company Option. However, any Company Option that has an exercise price per Ordinary Share that is greater than or equal to the Per Share Cash Consideration was cancelled and ceased to exist and the holder of any such Company Option was not entitled to payment of any consideration therefor."}],"balance_after":0,"derivative":{"exercise_price":23.85,"expiration_date":"2029-04-29","underlying":"Ordinary Shares","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001625377-26-000007","document":"form4-09252026_120902.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1625377/000162537726000007/form4-09252026_120902.xml","form_type":"4"}},{"id":4626571,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2026-09-25T00:36:06.000Z","date":"2026-09-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":6000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the Effective Time, each option to purchase Ordinary Shares outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested (a \"Company Option\"), was cancelled and converted into the right to receive an amount in cash, without interest, equal to (i) the excess, if any, of the Per Share Cash Consideration over the exercise price of such Company Option, multiplied by (ii) the number of Ordinary Shares underlying such Company Option plus (iii) one CVR for each Ordinary Share underlying such Company Option. However, any Company Option that has an exercise price per Ordinary Share that is greater than or equal to the Per Share Cash Consideration was cancelled and ceased to exist and the holder of any such Company Option was not entitled to payment of any consideration therefor."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the Effective Time, each option to purchase Ordinary Shares outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested (a \"Company Option\"), was cancelled and converted into the right to receive an amount in cash, without interest, equal to (i) the excess, if any, of the Per Share Cash Consideration over the exercise price of such Company Option, multiplied by (ii) the number of Ordinary Shares underlying such Company Option plus (iii) one CVR for each Ordinary Share underlying such Company Option. However, any Company Option that has an exercise price per Ordinary Share that is greater than or equal to the Per Share Cash Consideration was cancelled and ceased to exist and the holder of any such Company Option was not entitled to payment of any consideration therefor."}],"balance_after":0,"derivative":{"exercise_price":24.43,"expiration_date":"2028-04-30","underlying":"Ordinary Shares","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001625377-26-000007","document":"form4-09252026_120902.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1625377/000162537726000007/form4-09252026_120902.xml","form_type":"4"}},{"id":4626570,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-09-25T00:36:06.000Z","date":"2026-09-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":6009,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the Effective Time, pursuant to the Merger Agreement, each award of restricted stock units of the Issuer (a \"Company RSU Award\") that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive an amount in cash, without interest, equal to (i) the Per Share Cash Consideration multiplied by (ii) the number of Ordinary Shares underlying such Company RSU Award (subject to any required tax withholdings as provided in the Merger Agreement) plus (iii) one CVR for each Ordinary Share underlying such Company RSU Award."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001625377-26-000007","document":"form4-09252026_120902.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1625377/000162537726000007/form4-09252026_120902.xml","form_type":"4"}},{"id":4626569,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-09-25T00:36:06.000Z","date":"2026-09-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":74204,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 23, 2026, pursuant to that certain Agreement and Plan of Merger (the \"Merger Agreement\"), dated June 28, 2026, by and among the Issuer, Zymeworks Inc. (\"Parent\"), and Zymeworks Merger Sub 1, a wholly owned subsidiary of Parent, the Issuer became a wholly owned subsidiary of Parent (the \"Merger\"). At the effective time of the Merger (the \"Effective Time\"), pursuant to the Merger Agreement, each ordinary share, par value $0.00001 per share, of the Issuer (\"Ordinary Share\") held by the reporting person as of immediately prior to the Effective Time was cancelled and converted into the right to receive (i) $17.00 in cash, without interest (the \"Per Share Cash Consideration\") and (ii) one contingent value right (a \"CVR\"). Each CVR represents a non-tradeable contractual contingent right to receive cash payments based on the achievement of certain commercial milestones following the Effective Time."}],"balance_after":6009,"source":{"system":"sec-edgar","filing":"0001625377-26-000007","document":"form4-09252026_120902.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1625377/000162537726000007/form4-09252026_120902.xml","form_type":"4"}},{"id":735839,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2026-06-17T01:36:48.000Z","date":"2026-06-12","kind":"grant","planned":false,"acquired":true,"shares":13398,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date."}],"balance_after":13398,"derivative":{"exercise_price":16.64,"expiration_date":"2036-06-11","underlying":"Ordinary Shares","underlying_shares":13398},"source":{"system":"sec-edgar","filing":"0001625377-26-000004","document":"form4-06172026_010644.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000162537726000004/form4-06172026_010644.xml","form_type":"4"}},{"id":735838,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-17T01:36:48.000Z","date":"2026-06-12","kind":"grant","planned":false,"acquired":true,"shares":6009,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":80213,"source":{"system":"sec-edgar","filing":"0001625377-26-000004","document":"form4-06172026_010644.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000162537726000004/form4-06172026_010644.xml","form_type":"4"}},{"id":776653,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-15T17:15:24.000Z","date":"2026-05-14","kind":"exercise","planned":false,"acquired":false,"shares":7305,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 14 May 2026."}],"balance_after":0,"derivative":{"exercise_date":"2026-05-14","underlying":"Ordinary Shares","underlying_shares":7305},"source":{"system":"sec-edgar","filing":"0001625377-26-000002","document":"wk-form4_1778865321.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1585364/000162537726000002/wk-form4_1778865321.xml","form_type":"4"}},{"id":776652,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-15T17:15:24.000Z","date":"2026-05-13","kind":"grant","planned":false,"acquired":true,"shares":16681,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on May 13 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on May 13 2027."}],"balance_after":16681,"derivative":{"underlying":"Ordinary Shares","underlying_shares":16681},"source":{"system":"sec-edgar","filing":"0001625377-26-000002","document":"wk-form4_1778865321.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1585364/000162537726000002/wk-form4_1778865321.xml","form_type":"4"}},{"id":776651,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-05-15T17:15:24.000Z","date":"2026-05-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":3507,"price":10.84,"value":38015.88,"ownership":{"direct":true},"balance_after":34435,"source":{"system":"sec-edgar","filing":"0001625377-26-000002","document":"wk-form4_1778865321.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1585364/000162537726000002/wk-form4_1778865321.xml","form_type":"4"}},{"id":776650,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-05-15T17:15:24.000Z","date":"2026-05-14","kind":"exercise","planned":false,"acquired":true,"shares":7305,"price":10.84,"value":79186.2,"ownership":{"direct":true},"balance_after":37942,"source":{"system":"sec-edgar","filing":"0001625377-26-000002","document":"wk-form4_1778865321.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1585364/000162537726000002/wk-form4_1778865321.xml","form_type":"4"}},{"id":1138656,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2025-05-21T23:17:55.000Z","date":"2025-05-19","kind":"grant","planned":false,"acquired":true,"shares":24258,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date."}],"balance_after":24258,"derivative":{"exercise_price":9.39,"expiration_date":"2035-05-18","underlying":"Ordinary Shares","underlying_shares":24258},"source":{"system":"sec-edgar","filing":"0001415889-25-014017","document":"form4-05212025_110551.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000141588925014017/form4-05212025_110551.xml","form_type":"4"}},{"id":1138655,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-05-21T23:17:55.000Z","date":"2025-05-19","kind":"grant","planned":false,"acquired":true,"shares":10649,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":74204,"source":{"system":"sec-edgar","filing":"0001415889-25-014017","document":"form4-05212025_110551.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000141588925014017/form4-05212025_110551.xml","form_type":"4"}},{"id":1144832,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-05-16T15:52:45.000Z","date":"2025-05-14","kind":"exercise","planned":false,"acquired":false,"shares":9904,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 14 May 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 14 May 2025."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":9904},"source":{"system":"sec-edgar","filing":"0001585364-25-000075","document":"wk-form4_1747410758.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1585364/000158536425000075/wk-form4_1747410758.xml","form_type":"4"}},{"id":1144831,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-05-16T15:52:45.000Z","date":"2025-05-14","kind":"grant","planned":false,"acquired":true,"shares":7305,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 14 May 2026."}],"balance_after":7305,"derivative":{"exercise_date":"2026-05-14","underlying":"Ordinary Shares","underlying_shares":7305},"source":{"system":"sec-edgar","filing":"0001585364-25-000075","document":"wk-form4_1747410758.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1585364/000158536425000075/wk-form4_1747410758.xml","form_type":"4"}},{"id":1144830,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-05-16T15:52:45.000Z","date":"2025-05-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":4754,"price":26.01,"value":123651.54,"ownership":{"direct":true},"balance_after":30637,"source":{"system":"sec-edgar","filing":"0001585364-25-000075","document":"wk-form4_1747410758.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1585364/000158536425000075/wk-form4_1747410758.xml","form_type":"4"}},{"id":1144829,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-05-16T15:52:45.000Z","date":"2025-05-14","kind":"exercise","planned":false,"acquired":true,"shares":9904,"price":26.01,"value":257603.04,"ownership":{"direct":true},"balance_after":35391,"source":{"system":"sec-edgar","filing":"0001585364-25-000075","document":"wk-form4_1747410758.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1585364/000158536425000075/wk-form4_1747410758.xml","form_type":"4"}},{"id":1513835,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-05-16T23:28:21.000Z","date":"2024-05-15","kind":"exercise","planned":false,"acquired":false,"shares":8764,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 15 May 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 15 May 2024."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":8764},"source":{"system":"sec-edgar","filing":"0001585364-24-000089","document":"wk-form4_1715902083.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1585364/000158536424000089/wk-form4_1715902083.xml","form_type":"4"}},{"id":1513834,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-05-16T23:28:21.000Z","date":"2024-05-14","kind":"grant","planned":false,"acquired":true,"shares":9904,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 14 May 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 14 May 2025."}],"balance_after":9904,"derivative":{"underlying":"Ordinary Shares","underlying_shares":9904},"source":{"system":"sec-edgar","filing":"0001585364-24-000089","document":"wk-form4_1715902083.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1585364/000158536424000089/wk-form4_1715902083.xml","form_type":"4"}},{"id":1513833,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2024-05-16T23:28:21.000Z","date":"2024-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":4207,"price":30.22,"value":127135.54,"ownership":{"direct":true},"balance_after":25487,"source":{"system":"sec-edgar","filing":"0001585364-24-000089","document":"wk-form4_1715902083.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1585364/000158536424000089/wk-form4_1715902083.xml","form_type":"4"}},{"id":1513832,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2024-05-16T23:28:21.000Z","date":"2024-05-15","kind":"exercise","planned":false,"acquired":true,"shares":8764,"price":30.22,"value":264848.08,"ownership":{"direct":true},"balance_after":29694,"source":{"system":"sec-edgar","filing":"0001585364-24-000089","document":"wk-form4_1715902083.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1585364/000158536424000089/wk-form4_1715902083.xml","form_type":"4"}},{"id":1520373,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2024-05-10T22:10:52.000Z","date":"2024-05-08","kind":"grant","planned":false,"acquired":true,"shares":23576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date."}],"balance_after":23576,"derivative":{"exercise_price":9.49,"expiration_date":"2034-05-07","underlying":"Ordinary Shares","underlying_shares":23576},"source":{"system":"sec-edgar","filing":"0001415889-24-012917","document":"form4-05102024_100546.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000141588924012917/form4-05102024_100546.xml","form_type":"4"}},{"id":1520372,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2024-05-10T22:10:52.000Z","date":"2024-05-08","kind":"grant","planned":false,"acquired":true,"shares":10537,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":63555,"source":{"system":"sec-edgar","filing":"0001415889-24-012917","document":"form4-05102024_100546.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000141588924012917/form4-05102024_100546.xml","form_type":"4"}},{"id":1884127,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-05-19T18:38:51.000Z","date":"2023-05-17","kind":"exercise","planned":false,"acquired":false,"shares":7778,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Vesting of service-based restricted stock units granted on 17 May 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 17 May 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 17 May 2023."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":7778},"source":{"system":"sec-edgar","filing":"0001585364-23-000097","document":"wf-form4_168452151725680.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1585364/000158536423000097/wf-form4_168452151725680.xml","form_type":"4"}},{"id":1884126,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-05-19T18:38:51.000Z","date":"2023-05-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":3734,"price":32.86,"value":122699.24,"ownership":{"direct":true},"balance_after":20930,"source":{"system":"sec-edgar","filing":"0001585364-23-000097","document":"wf-form4_168452151725680.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1585364/000158536423000097/wf-form4_168452151725680.xml","form_type":"4"}},{"id":1884125,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-05-19T18:38:51.000Z","date":"2023-05-17","kind":"exercise","planned":false,"acquired":true,"shares":7778,"price":32.86,"value":255585.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Vesting of service-based restricted stock units granted on 17 May 2022."}],"balance_after":24664,"source":{"system":"sec-edgar","filing":"0001585364-23-000097","document":"wf-form4_168452151725680.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1585364/000158536423000097/wf-form4_168452151725680.xml","form_type":"4"}},{"id":1888397,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-05-18T00:14:08.000Z","date":"2023-05-15","kind":"grant","planned":false,"acquired":true,"shares":8764,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 15 May 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 15 May 2024."}],"balance_after":8764,"derivative":{"underlying":"Ordinary Shares","underlying_shares":8764},"source":{"system":"sec-edgar","filing":"0001585364-23-000084","document":"wf-form4_168436883085217.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1585364/000158536423000084/wf-form4_168436883085217.xml","form_type":"4"}},{"id":1904042,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2023-05-04T22:46:42.000Z","date":"2023-05-02","kind":"grant","planned":false,"acquired":true,"shares":22044,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date."}],"balance_after":22044,"derivative":{"exercise_price":10.95,"expiration_date":"2033-05-01","underlying":"Ordinary Shares","underlying_shares":22044},"source":{"system":"sec-edgar","filing":"0001415889-23-007382","document":"form4-05042023_100535.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000141588923007382/form4-05042023_100535.xml","form_type":"4"}},{"id":1904041,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-05-04T22:46:42.000Z","date":"2023-05-02","kind":"grant","planned":false,"acquired":true,"shares":9132,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":53018,"source":{"system":"sec-edgar","filing":"0001415889-23-007382","document":"form4-05042023_100535.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000141588923007382/form4-05042023_100535.xml","form_type":"4"}},{"id":2104910,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-11-23T23:57:53.000Z","date":"2022-11-22","kind":"disposition_to_issuer","acquired":false,"shares":10000,"price":10.5,"value":105000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents ordinary shares tendered by the reporting person and accepted for payment and purchased by the issuer in the issuer's Dutch auction tender offer for up to $95 million of its ordinary shares."}],"balance_after":43886,"source":{"system":"sec-edgar","filing":"0001415889-22-011763","document":"form4-11232022_111144.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000141588922011763/form4-11232022_111144.xml","form_type":"4"}},{"id":2263169,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-05-19T17:54:23.000Z","date":"2022-05-17","kind":"exercise","acquired":false,"shares":6599,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Vesting of service-based restricted stock units granted on 17 May 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 17 May 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 17 May 2022."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":6599},"source":{"system":"sec-edgar","filing":"0001585364-22-000057","document":"wf-form4_165298284498196.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1585364/000158536422000057/wf-form4_165298284498196.xml","form_type":"4"}},{"id":2263168,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-05-19T17:54:23.000Z","date":"2022-05-17","kind":"grant","acquired":true,"shares":7778,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 17 May 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 17 May 2023."}],"balance_after":7778,"derivative":{"underlying":"Ordinary Shares","underlying_shares":7778},"source":{"system":"sec-edgar","filing":"0001585364-22-000057","document":"wf-form4_165298284498196.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1585364/000158536422000057/wf-form4_165298284498196.xml","form_type":"4"}},{"id":2263167,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-05-19T17:54:23.000Z","date":"2022-05-17","kind":"tax_withholding","acquired":false,"shares":3168,"price":38.57,"value":122189.76,"ownership":{"direct":true},"balance_after":16886,"source":{"system":"sec-edgar","filing":"0001585364-22-000057","document":"wf-form4_165298284498196.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1585364/000158536422000057/wf-form4_165298284498196.xml","form_type":"4"}},{"id":2263166,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-05-19T17:54:23.000Z","date":"2022-05-17","kind":"exercise","acquired":true,"shares":6599,"price":38.57,"value":254523.43,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Vesting of service-based restricted stock units granted on 17 May 2021."}],"balance_after":20054,"source":{"system":"sec-edgar","filing":"0001585364-22-000057","document":"wf-form4_165298284498196.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1585364/000158536422000057/wf-form4_165298284498196.xml","form_type":"4"}},{"id":2288573,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2022-04-29T01:18:50.000Z","date":"2022-04-26","kind":"grant","acquired":true,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date."}],"balance_after":28000,"derivative":{"exercise_price":10.15,"expiration_date":"2032-04-25","underlying":"Ordinary Shares","underlying_shares":28000},"source":{"system":"sec-edgar","filing":"0001415889-22-004334","document":"form4-04282022_060449.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000141588922004334/form4-04282022_060449.xml","form_type":"4"}},{"id":2288572,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-04-29T01:18:50.000Z","date":"2022-04-26","kind":"grant","acquired":true,"shares":9852,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":53886,"source":{"system":"sec-edgar","filing":"0001415889-22-004334","document":"form4-04282022_060449.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000141588922004334/form4-04282022_060449.xml","form_type":"4"}},{"id":2704867,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-05-19T16:59:49.000Z","date":"2021-05-17","kind":"grant","acquired":true,"shares":6599,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 17 May 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 17 May 2022."}],"balance_after":6599,"derivative":{"underlying":"Ordinary Shares","underlying_shares":6599},"source":{"system":"sec-edgar","filing":"0001585364-21-000086","document":"wf-form4_162144357140600.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1585364/000158536421000086/wf-form4_162144357140600.xml","form_type":"4"}},{"id":2718099,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-05-11T18:56:30.000Z","date":"2021-05-07","kind":"exercise","acquired":false,"shares":5804,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Vesting of service-based restricted stock units granted on 7 May 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 7 May 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 7 May 2021."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":5804},"source":{"system":"sec-edgar","filing":"0001585364-21-000058","document":"wf-form4_162075937511440.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1585364/000158536421000058/wf-form4_162075937511440.xml","form_type":"4"}},{"id":2718098,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-05-11T18:56:30.000Z","date":"2021-05-07","kind":"tax_withholding","acquired":false,"shares":2786,"price":42.96,"value":119686.56,"ownership":{"direct":true},"balance_after":13455,"source":{"system":"sec-edgar","filing":"0001585364-21-000058","document":"wf-form4_162075937511440.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1585364/000158536421000058/wf-form4_162075937511440.xml","form_type":"4"}},{"id":2718097,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-05-11T18:56:30.000Z","date":"2021-05-07","kind":"exercise","acquired":true,"shares":5804,"price":42.96,"value":249339.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Vesting of service-based restricted stock units granted on 7 May 2020."}],"balance_after":16241,"source":{"system":"sec-edgar","filing":"0001585364-21-000058","document":"wf-form4_162075937511440.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1585364/000158536421000058/wf-form4_162075937511440.xml","form_type":"4"}},{"id":2735506,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2021-04-29T22:14:04.000Z","date":"2021-04-27","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date."}],"balance_after":6000,"derivative":{"exercise_price":20.35,"expiration_date":"2031-04-26","underlying":"Ordinary Shares","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001179110-21-004702","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911021004702/edgar.xml","form_type":"4"}},{"id":2735505,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-04-29T22:14:04.000Z","date":"2021-04-27","kind":"grant","acquired":true,"shares":9828,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":44034,"source":{"system":"sec-edgar","filing":"0001179110-21-004702","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911021004702/edgar.xml","form_type":"4"}},{"id":3142099,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-05-20T00:41:24.000Z","date":"2020-05-15","kind":"exercise","acquired":false,"shares":6054,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Vesting of service-based restricted stock units granted on May 15, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."}],"balance_after":0,"derivative":{"exercise_date":"2020-05-15","expiration_date":"2020-05-15","underlying":"Ordinary Shares","underlying_shares":6054},"source":{"system":"sec-edgar","filing":"0001585364-20-000065","document":"wf-form4_158993525971538.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1585364/000158536420000065/wf-form4_158993525971538.xml","form_type":"4"}},{"id":3142098,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2020-05-20T00:41:24.000Z","date":"2020-05-15","kind":"tax_withholding","acquired":false,"shares":2906,"price":52.76,"value":153320.56,"ownership":{"direct":true},"balance_after":10437,"source":{"system":"sec-edgar","filing":"0001585364-20-000065","document":"wf-form4_158993525971538.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1585364/000158536420000065/wf-form4_158993525971538.xml","form_type":"4"}},{"id":3142097,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2020-05-20T00:41:24.000Z","date":"2020-05-15","kind":"exercise","acquired":true,"shares":6054,"price":52.76,"value":319409.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Vesting of service-based restricted stock units granted on May 15, 2019."}],"balance_after":13343,"source":{"system":"sec-edgar","filing":"0001585364-20-000065","document":"wf-form4_158993525971538.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1585364/000158536420000065/wf-form4_158993525971538.xml","form_type":"4"}},{"id":3153943,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-05-11T20:49:12.000Z","date":"2020-05-07","kind":"grant","acquired":true,"shares":5804,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 7 May 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 7 May 2021."}],"balance_after":5804,"derivative":{"underlying":"Ordinary Shares","underlying_shares":5804},"source":{"system":"sec-edgar","filing":"0001585364-20-000053","document":"wf-form4_158923013441164.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1585364/000158536420000053/wf-form4_158923013441164.xml","form_type":"4"}},{"id":3166265,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2020-04-30T23:04:50.000Z","date":"2020-04-28","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date."}],"balance_after":6000,"derivative":{"exercise_price":30.14,"expiration_date":"2030-04-27","underlying":"Ordinary Shares","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001179110-20-005304","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911020005304/edgar.xml","form_type":"4"}},{"id":3166264,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2020-04-30T23:04:50.000Z","date":"2020-04-28","kind":"grant","acquired":true,"shares":6635,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":34206,"source":{"system":"sec-edgar","filing":"0001179110-20-005304","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911020005304/edgar.xml","form_type":"4"}},{"id":3518019,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-05-20T22:02:08.000Z","date":"2019-05-17","kind":"sale","acquired":false,"shares":2673,"price":20.1899,"value":53967.6027,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices from $20.181000 to $20.2274. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":27571,"source":{"system":"sec-edgar","filing":"0001179110-19-006410","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911019006410/edgar.xml","form_type":"4"}},{"id":3518018,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-05-20T22:02:08.000Z","date":"2019-05-16","kind":"sale","acquired":false,"shares":1327,"price":21,"value":27867.0,"ownership":{"direct":true},"balance_after":30244,"source":{"system":"sec-edgar","filing":"0001179110-19-006410","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911019006410/edgar.xml","form_type":"4"}},{"id":3520131,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-05-17T19:58:34.000Z","date":"2019-05-15","kind":"exercise","acquired":false,"shares":3971,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Vesting of service-based restricted stock units granted on May 15, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."}],"balance_after":0,"derivative":{"exercise_date":"2019-05-15","expiration_date":"2019-05-15","underlying":"Ordinary Shares","underlying_shares":3971},"source":{"system":"sec-edgar","filing":"0001585364-19-000066","document":"wf-form4_155812309988989.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1585364/000158536419000066/wf-form4_155812309988989.xml","form_type":"4"}},{"id":3520130,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-05-17T19:58:34.000Z","date":"2019-05-15","kind":"grant","acquired":true,"shares":6054,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."}],"balance_after":6054,"derivative":{"exercise_date":"2020-05-15","expiration_date":"2020-05-15","underlying":"Ordinary Shares","underlying_shares":6054},"source":{"system":"sec-edgar","filing":"0001585364-19-000066","document":"wf-form4_155812309988989.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1585364/000158536419000066/wf-form4_155812309988989.xml","form_type":"4"}},{"id":3520129,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-05-17T19:58:34.000Z","date":"2019-05-15","kind":"tax_withholding","acquired":false,"shares":1907,"price":49.55,"value":94491.85,"ownership":{"direct":true},"balance_after":7289,"source":{"system":"sec-edgar","filing":"0001585364-19-000066","document":"wf-form4_155812309988989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1585364/000158536419000066/wf-form4_155812309988989.xml","form_type":"4"}},{"id":3520128,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-05-17T19:58:34.000Z","date":"2019-05-15","kind":"exercise","acquired":true,"shares":3971,"price":49.55,"value":196763.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Vesting of service-based restricted stock units granted on May 15, 2018."}],"balance_after":9196,"source":{"system":"sec-edgar","filing":"0001585364-19-000066","document":"wf-form4_155812309988989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1585364/000158536419000066/wf-form4_155812309988989.xml","form_type":"4"}},{"id":3541943,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2019-05-02T22:28:49.000Z","date":"2019-04-30","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date."}],"balance_after":6000,"derivative":{"exercise_price":23.85,"expiration_date":"2029-04-29","underlying":"Ordinary Shares","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001179110-19-005465","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911019005465/edgar.xml","form_type":"4"}},{"id":3541942,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-05-02T22:28:49.000Z","date":"2019-04-30","kind":"grant","acquired":true,"shares":8385,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":31571,"source":{"system":"sec-edgar","filing":"0001179110-19-005465","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911019005465/edgar.xml","form_type":"4"}},{"id":3899521,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-06-08T21:05:35.000Z","date":"2018-06-06","kind":"exercise","acquired":true,"shares":4265,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."}],"balance_after":0,"derivative":{"exercise_date":"2018-06-06","expiration_date":"2018-06-06","underlying":"Ordinary Shares","underlying_shares":4265},"source":{"system":"sec-edgar","filing":"0001585364-18-000040","document":"wf-form4_152849191938483.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1585364/000158536418000040/wf-form4_152849191938483.xml","form_type":"4"}},{"id":3899520,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2018-06-08T21:05:35.000Z","date":"2018-06-06","kind":"tax_withholding","acquired":false,"shares":2218,"price":73.22,"value":162401.96,"ownership":{"direct":true},"balance_after":5225,"source":{"system":"sec-edgar","filing":"0001585364-18-000040","document":"wf-form4_152849191938483.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1585364/000158536418000040/wf-form4_152849191938483.xml","form_type":"4"}},{"id":3899519,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2018-06-08T21:05:35.000Z","date":"2018-06-06","kind":"exercise","acquired":true,"shares":4265,"price":73.22,"value":312283.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Vesting of service-based restricted stock units granted on June 6, 2017."}],"balance_after":7443,"source":{"system":"sec-edgar","filing":"0001585364-18-000040","document":"wf-form4_152849191938483.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1585364/000158536418000040/wf-form4_152849191938483.xml","form_type":"4"}},{"id":3927462,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-05-17T20:43:12.000Z","date":"2018-05-15","kind":"grant","acquired":true,"shares":3971,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."}],"balance_after":3971,"derivative":{"exercise_date":"2019-05-15","expiration_date":"2019-05-15","underlying":"Ordinary Shares","underlying_shares":3971},"source":{"system":"sec-edgar","filing":"0001585364-18-000039","document":"wf-form4_152658977891770.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1585364/000158536418000039/wf-form4_152658977891770.xml","form_type":"4"}},{"id":3946843,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2018-05-03T22:17:13.000Z","date":"2018-05-01","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date."}],"balance_after":6000,"derivative":{"exercise_price":24.43,"expiration_date":"2028-04-30","underlying":"Ordinary Shares","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001179110-18-006193","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911018006193/edgar.xml","form_type":"4"}},{"id":3946842,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2018-05-03T22:17:13.000Z","date":"2018-05-01","kind":"grant","acquired":true,"shares":8186,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":23186,"source":{"system":"sec-edgar","filing":"0001179110-18-006193","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911018006193/edgar.xml","form_type":"4"}},{"id":4288008,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-06-08T18:18:00.000Z","date":"2017-06-06","kind":"grant","acquired":true,"shares":4265,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."}],"balance_after":4265,"derivative":{"exercise_date":"2018-06-06","expiration_date":"2018-06-06","underlying":"Ordinary Shares","underlying_shares":4265},"source":{"system":"sec-edgar","filing":"0001585364-17-000091","document":"wf-form4_149694586327915.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1585364/000158536417000091/wf-form4_149694586327915.xml","form_type":"4"}},{"id":4295114,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-06-02T16:37:26.000Z","date":"2017-05-31","kind":"exercise","acquired":false,"shares":3263,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Vesting of service-based restricted stock units granted on May 19, 2016."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Reporting Person had voluntarily agreed to postpone the vesting of this award until such time as the Issuer is current in its filings under the Securities Exchange Act of 1934."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Reporting Person had voluntarily agreed to postpone the vesting of this award until such time as the Issuer is current in its filings under the Securities Exchange Act of 1934."}],"balance_after":0,"derivative":{"exercise_date":"2017-05-19","expiration_date":"2017-05-19","underlying":"Ordinary Shares","underlying_shares":3263},"source":{"system":"sec-edgar","filing":"0001585364-17-000089","document":"wf-form4_149642142927368.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1585364/000158536417000089/wf-form4_149642142927368.xml","form_type":"4"}},{"id":4295113,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2017-06-02T16:37:26.000Z","date":"2017-05-31","kind":"tax_withholding","acquired":false,"shares":1697,"price":72.85,"value":123626.45,"ownership":{"direct":true},"balance_after":3178,"source":{"system":"sec-edgar","filing":"0001585364-17-000089","document":"wf-form4_149642142927368.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1585364/000158536417000089/wf-form4_149642142927368.xml","form_type":"4"}},{"id":4295112,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2017-06-02T16:37:26.000Z","date":"2017-05-31","kind":"exercise","acquired":true,"shares":3263,"price":72.85,"value":237709.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Vesting of service-based restricted stock units granted on May 19, 2016."}],"balance_after":4875,"source":{"system":"sec-edgar","filing":"0001585364-17-000089","document":"wf-form4_149642142927368.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1585364/000158536417000089/wf-form4_149642142927368.xml","form_type":"4"}},{"id":4311322,"issuer":{"id":4516,"kind":"organization","name":"PERRIGO Co plc","symbol":"PRGO"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-05-19T17:27:11.000Z","date":"2016-05-19","kind":"grant","acquired":true,"shares":3263,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Reporting Person has voluntarily agreed to postpone the vesting of this award until such time as the Issuer is current in its filings under the Securities Exchange Act of 1934."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Reporting Person has voluntarily agreed to postpone the vesting of this award until such time as the Issuer is current in its filings under the Securities Exchange Act of 1934."}],"balance_after":3263,"derivative":{"exercise_date":"2017-05-19","expiration_date":"2017-05-19","underlying":"Ordinary Shares","underlying_shares":3263},"source":{"system":"sec-edgar","filing":"0001585364-17-000058","document":"wf-form4a_149521481631250.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1585364/000158536417000058/wf-form4a_149521481631250.xml","form_type":"4/A","original_submission_date":"2016-05-23"}},{"id":4313142,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":37595,"kind":"person","name":"O'Connor Donal","position":1,"cik":"0001625377","reported_name":"O'Connor Donal","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2017-05-18T22:05:00.000Z","date":"2017-05-17","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001179110-17-007544","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911017007544/edgar.xml","form_type":"4"}}]}